BERLIN — Germany's Bayer AG says it plans to buy U.S. pharmaceutical company Merck & Co. Inc.'s consumer care business, whose products include the Coppertone suncare range, Claritin allergy medicine and the Dr. Scholl's footcare products, for $14.2 billion.
Bayer CEO Marijn Dekkers said Tuesday that the planned acquisition "marks a major milestone on our path towards global leadership in the attractive non-prescription medicines business."
Bayer said that it also has entered an agreement with Merck to cooperate on developing potential cardiovascular treatments, with Merck initially paying Bayer $1 billion and further payments contingent on sales.
Keep up to date with what’s happening in Turkey,
it’s region and the world.
You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
